Posts tagged “Novozymes”
What is the animal miocrobiome and how will it affect agriculture in North Carolina? That's the question that will be addressed at the ag Biotech professional for March 23 at the North Carolina biotech center.
In today's Bulldog wrapup of technology and life science news: Lenovo fights lawsuits over adware; Google pays back taxes in U.K.; GSK puts $15 million in new university drug development fund; and Novozymes launches a poultry product with French partner.
Novozymes, the global industrial enzyme producer which employs more than 500 people across the triangle region, is spinning off its biopharma unit as a separate company. The Denmark-based company also says that falling commodity prices will impact growth.
In today's Bulldog wrapup of life science and biotech news: Valenat, which operates Sprout Pharmaceuticals and Salix in Raleigh, has a new CEO; Novozymes and Monsanto move toward first crop product in 2017; and Monsanto plans 1,000 job cuts.
Novozymes, which has a huge operation in Franklinton and is the world's largest provider of enzymes and other technologies to create biofuels, reacted angrily to new EPA guidelines for biofuel and ethanol production issued Monday. The company wanted the government to require more biofuels but it says the President and the EPA "didn't go all-in.'
In today's Bulldog wrapup of technology news, reports say Twitter is in talks to acquire Flipboard; Novozymes to start operations of new $11M waste-to-energy system; Charlotte holding extended Google I/O event.
The company will build a new bioagriculture research and development facility in Cary. The company said it will invest $36 million over the next three years and create 100 new jobs at the facility. Salaries will start at $70,000.
Novozymes and Monsanto are teaming up to discover, develop and commercialize microbes that could be used in sustainable agriculture. WRALTechWire takes an inside look at the deal and what both firms are bringing to the table.
Crop giant Monsanto is teaming up with microbial and enzyme technology firm Novozymes to form a partnership that will target development of bioagricultural products that the companies say will be "sustainable." The deal includes a $300 million upfront payment to Novozymes, which operates its North American headquarters in Franklinton.
Biochemtex, which is a partner in a joint venture with Novozymes, says it will build the biofuels plant and create 65 jobs over three years. The company could receive $300,000 from the state's One North Carolina if it meets objectives.
Opinion: What should have been a balanced media report on the impacts of the ethanol industry on land conservation, turned into a tale that isn't really what it seems, says the president of North Carolina-based Novozymes America.
BASF's planned acquisition of biotech company Verenium is just the latest in a string of moves by the chemicals company to challenge industrial enzymes leaders Novozymes and Dupont. Read more about the deal.
Novozymes' bioyield enhancers portfolio is getting bigger through the aquisition of agbio company TJ Technologies. Learn why Novozymes wants this South Dakota company.
Novozymes technology promises to increase the active life of the new diabetes drug, meaning type 2 diabetes sufferers could inject once a week instead of daily. Novozymes uses genetically modified proteins that allow GSK to fuse its drug with albumin found in blood serum, fooling the body into accepting the active ingredients that it would normally deem foreign and expel.
- Women-led startups flex muscles at healthcare investment showcase
- Tech links: Epic v. Microsoft; Wilmington at Forbes; IBM blockchain; Arista-Cisco patent fight; IBM cloud foundation; GSK malaria vaccine
- Triangle headlines: RTI-Zika research; Quintiles glucose monitoring; Cree's LED plant lights; PatientPay exec; Q2 award